Filing Details
- Accession Number:
- 0001493152-25-001015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-06 16:37:06
- Reporting Period:
- 2025-01-02
- Accepted Time:
- 2025-01-06 16:37:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1468929 | Nexgel Inc. | NXGL | Surgical & Medical Instruments & Apparatus (3841) | 264042544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1794090 | R. Adam Levy | C/O Nexgel, Inc. 2150 Cabot Blvd, West, Suite B Langhorne PA 19047 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock (Restricted Stock Units) | Acquisiton | 2025-01-02 | 26,116 | $0.00 | 386,284 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-01-02 | 4,000 | $3.96 | 382,284 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Acquisiton | 2025-01-02 | 150,000 | $0.00 | 150,000 | $3.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 150,000 | 2030-01-02 | No | 4 | A | Direct |
Footnotes
- The restricted stock units were granted to the Reporting Person in connection with his 2025 executive employment agreement with the Issuer. The restricted stock units vest in twelve equal monthly installments (subject to any rounding adjustments) during the term of the Levy Employment Agreement with the first installment vesting on January 2, 2025 provided the Reporting Person is employed on the applicable vesting date by the Issuer.
- The Reporting Person sold these shares pursuant to a Rule 10b5-1 trading plan instituted for tax planning purposes. The shares were originally acquired by the Reporting Person from the Issuer on October 15, 2019 and were not purchased in the recent registered direct offerings of the Issuer.
- Represents the weighted average of open market sale transactions ranging from $3.61 to $4.42 per share. The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price sold if requested by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
- The stock options were granted to the Reporting Person in connection with his 2025 executive employment agreement with the Issuer. The stock options vest as follows: 37,500 shares of Common Stock on December 31, 2025, 2026, 2027 and 2028, respectively, provided the Reporting Person is employed on the applicable vesting date by the Issuer.
Billionaire Hedge Funds
